Targeted/Chemo Combo Effective in Preclinical pNETs Study
Combining the chemotherapy streptozotocin with various mTOR inhibitors was found to effectively target tumors in preclinical studies for pancreatic neuroendocrine tumors (pNETs).
Capecitabine/Temozolomide Effective in Pancreatic NETs
Treatment with capecitabine and temozolomide is an effective therapy for patients with metastatic pancreatic neuroendocrine tumors.
Survival Reaches 90% With Full Resection in Gastroenteropancreatic NETs